Simulations Plus, based in Lancaster, California, offers modeling software and consulting services for drug discovery, employing 192 staff and providing 12 software products and various pharmacokinetic services. Their expertise spans from early drug development to regulatory submissions and includes training solutions for clinical trials.
Based on our analysis, Simulations Plus has recently received an overvalued rating of 1 out of 5 stars from Cashu, primarily due to its high financial ratios compared to the sector averages.
One critical metric is the Price-to-Earnings (PE) Ratio, which stands at 88.72, significantly higher than the sector average of 15.06. A high PE ratio indicates that investors are paying much more for each dollar of earnings, suggesting that the stock may be overpriced relative to its earnings potential.
Another concerning ratio is the Price-to-Book (PB) Ratio, which is 3.98, compared to the sector's average of 2.72. The PB ratio measures a company's market value relative to its book value. A higher ratio can indicate overvaluation, as investors may be paying a premium for the company's assets.
While Simulations Plus boasts a positive Net Profit Margin of 14.22, which is an indicator of profitability, it is important to compare this with the sector's alarming figure of -145.98. This disparity signifies that although the company is profitable, its valuation may not be justified when considering the broader industry's struggles.
Moreover, the Return on Equity (ROE) Ratio stands at 5.46, while the sector average is a stark -74.88. While a positive ROE indicates some effectiveness in generating profits from shareholders' equity, the low figure suggests limited return potential relative to investor expectations in the sector.
This is not a comprehensive overview of our valuation, and should not be viewed as financial advice. Always do your own research before considering an investment.
📡️ Health Care
Overvalued
More Signals
Feature in Progress
This section is under development. Check back soon for updates!